Marie Kassapian

615 total citations
7 papers, 142 citations indexed

About

Marie Kassapian is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Marie Kassapian has authored 7 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Cancer Research. Recurrent topics in Marie Kassapian's work include Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and HER2/EGFR in Cancer Research (2 papers). Marie Kassapian is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and HER2/EGFR in Cancer Research (2 papers). Marie Kassapian collaborates with scholars based in Switzerland, Greece and Spain. Marie Kassapian's co-authors include Rolf A. Stahel, Antonio Irigoyen López, Matthias Gückenberger, Solange Peters, Anne‐Christine Piguet, Maarten Lambrecht, Nicolaus Andratschke, Enriqueta Felip, Johan Vansteenkiste and Urania Dafni and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Marie Kassapian

5 papers receiving 142 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie Kassapian Switzerland 2 120 101 26 14 5 7 142
Karim Amrane France 5 105 0.9× 70 0.7× 26 1.0× 20 1.4× 8 1.6× 18 133
Ilias Houda Netherlands 6 108 0.9× 80 0.8× 27 1.0× 13 0.9× 9 1.8× 13 141
Juan Carlos Vázquez Limón United States 7 82 0.7× 75 0.7× 45 1.7× 8 0.6× 4 0.8× 10 101
Aanika Balaji United States 5 128 1.1× 70 0.7× 19 0.7× 8 0.6× 3 0.6× 13 151
Oladimeji Akinboro United States 5 114 0.9× 101 1.0× 14 0.5× 9 0.6× 4 0.8× 15 148
J. Remon Masip France 5 108 0.9× 95 0.9× 15 0.6× 8 0.6× 7 1.4× 23 135
Joaquín Casal‐Rubio Spain 4 83 0.7× 79 0.8× 10 0.4× 10 0.7× 2 0.4× 5 116
N. Girard France 4 81 0.7× 73 0.7× 19 0.7× 11 0.8× 3 0.6× 24 110
E. Felip Font Spain 6 89 0.7× 77 0.8× 20 0.8× 7 0.5× 1 0.2× 15 109
Dae Ho Lee South Korea 4 171 1.4× 110 1.1× 33 1.3× 4 0.3× 6 1.2× 6 182

Countries citing papers authored by Marie Kassapian

Since Specialization
Citations

This map shows the geographic impact of Marie Kassapian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Kassapian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Kassapian more than expected).

Fields of papers citing papers by Marie Kassapian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Kassapian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Kassapian. The network helps show where Marie Kassapian may publish in the future.

Co-authorship network of co-authors of Marie Kassapian

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Kassapian. A scholar is included among the top collaborators of Marie Kassapian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Kassapian. Marie Kassapian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Martins-Branco, Diogo, Marie Kassapian, Véronique Debien, et al.. (2023). The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study. Breast Cancer Research and Treatment. 203(3). 497–509.
2.
Marta, Guilherme Nader, Véronique Debien, Daniel Eiger, et al.. (2022). Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy—a sub-analysis of the ALTTO study. British Journal of Cancer. 127(10). 1799–1807. 1 indexed citations
3.
4.
Felip, Enriqueta, Urania Dafni, Oliver Gautschi, et al.. (2018). Evolution and clinical impact of EGFR mutations in circulating free DNA in the BELIEF trial. Annals of Oncology. 29. viii513–viii513. 1 indexed citations
5.
Peters, Solange, Dirk De Ruysscher, Urania Dafni, et al.. (2018). Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-RT regimen in unresectable locally advanced NSCLC: The ETOP NICOLAS phase II trial.. Journal of Clinical Oncology. 36(15_suppl). 8510–8510. 17 indexed citations
6.
7.
Callegaro, Andrea, Marie Kassapian, Toufik Zahaf, & Fabián Tibaldi. (2014). Statistical methods for the analysis of clinical trials data containing many zeros: An application in vaccine development. Statistical Methods in Medical Research. 25(6). 2811–2826. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karim Amrane Breakdown of academic impact, for papers by Ilias Houda Breakdown of academic impact, for papers by Juan Carlos Vázquez Limón Breakdown of academic impact, for papers by Aanika Balaji Breakdown of academic impact, for papers by Oladimeji Akinboro Breakdown of academic impact, for papers by J. Remon Masip Breakdown of academic impact, for papers by Joaquín Casal‐Rubio Breakdown of academic impact, for papers by N. Girard Breakdown of academic impact, for papers by E. Felip Font Breakdown of academic impact, for papers by Dae Ho Lee
Rankless by CCL
2026